spectrum.cookmedical.comCook Medical Spectrum Technology

Spectrum technology Home About Products Education FAQs Evidence & Guidelines VASCULAR ACCESS Meet the latest standards and guidelines Cook Spectrum ® CVCs allow you to meet the CDC 1A recommendation as a component of CRBSI prevention when process alone hasn’t helped you reach your infection prevention goals. Read More VASCULAR ACCESS Rely on proven CLABSI/CRBSI prevention technology More than 30 peer-reviewed studies and over two decades of clinical experience point to one simple solution: Cook Spectrum = proven CRBSI prevention technology. Read More VASCULAR ACCESS Choose from a comprehensive product offering Select from an array of CVC options in an unmatched variety of size and lumen configurations. Read More VASCULAR ACCESS Understanding the Hospital-Acquired Condition (HAC) Reduction Program Read More Previous Next Infections hurt. Help is here. Strive for a complete infection prevention strategy. As process guidelines have improved in recent years, so has infection control technology. Between maximal sterile barrier precautions and Cook Spectrum technology, the path to lowering the risk of central line-associated bloodstream infections (CLABSIs) and catheter-related bloodstream infections (CRBSIs) has never been more clear or more proven. Validated by over 30 references and sources and two decades of experience, Spectrum catheters are impregnated with minocycline and rifampin (M+R) to help patients by providing proven protection against CRBSIs. 1 Pursuing a Solution In 1994, Dr. Issam Raad researched and published studies on the beneficial impact of maximal sterile barrier precautions on CRBSI rates. His goal was to reach zero. He soon realized that process alone cannot reach and maintain zero. That’s why he turned his efforts toward developing anti-infection technology. Learn More Enhancing Education Cook Medical is proud to provide a variety of tools that are designed to educate clinicians, caregivers, and patients about Cook Spectrum technology and related products. Learn More Discovering Savings Treating a single CRBSI costs between $30,919 and $65,245. 4 The proven combination of minocycline and rifampin can help reduce your infection rate and make it worth switching to Spectrum catheters. Learn More References Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med . 1997;127(4):267-274. Schuerer DJ, Zack JE, Thomas J, et al. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial. Surg Infect (Larchmt) . 2007;8(4):445-454. Bonne S, Mazuski J, Sona C, et al. Effectiveness of minocycline and rifampin vs chlorhexidine and silver sulfadiazine-impregnated central venous catheters in preventing central line-associated bloodstream infection in a high-volume academic intensive care unit: a before and after trial. J Am Coll Surg . 2015;221(3):739-747. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med . 2013;173(22):2039-2046. © COOK 2023 Privacy Statement • Terms of Use • Cookie Compliance • Code of Conduct • Human Rights Responsibility Statement • Contact Us Not all products shown on this website may be approved in all regulatory jurisdictions. Consult with your local Cook representative, distribution company or customer service center for...